Following the publication on 21 March 2014 of the Regulation 282/2014 of the European Parliament and of the Council on the “Establishment of a third Programme for the Union's action in the field of health (2014-2020) “, on 11 April 2014 the European Commission, Directorate General for Health and Consumers (DG SANCO) hosted an the Information Day on the 3rd European Health Programme.
Concerning the relevance for EAMBES in terms of potential funding, two issues have to be underlined:
On one hand, amongst the three available funding lines, only one (Project Grants) foresees the participation of the private sector. However, during the Conference it was underlined that the Programme is not designed to finance projects that seek to produce an economic benefit (including funding for research). That would limit the use of the funding to the covering of actions of a “corporate social responsibility” nature (reinforcing European Reference Networks, supporting the action of patients’ organisations and patients’ information etc.) or to finance pilot projects in collaboration with public organisations seeking to reinforce one of the priorities yearly announced through the Commission’s Annual Work Programmes.
On the other, another possibility would be to promote projects to be initiated both by Health Authorities (Joint Actions) or by bodies working in the field of health (research centres, universities, health institutions, NGOs, patients’ associations) to apply for funding for projects that could indirectly benefit the interests of X through future procurement needs. The development of such projects could in the medium-term be beneficial for X’s commercial interests.
As announced during the conference, the European Commission adopted on 26 May 2014 the “Work programme for 2014 in the framework of the third Programme of the Union's action in the field of health (2014-2020)”.
Further information can be accessed here